21 March 2018
News and Views
Links and Services
A study in the latest issue of the European Journal of Gastroenterology & Hepatology evaluated noninvasive methods to predict advanced fibrosis in patients with hepatitis B and C.
Noninvasive tests are primarily used for staging hepatic fibrosis in patients with chronic liver
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors